Moomoo AI 已提取核心信息
AbbVie Inc. (AbbVie) has announced the upcoming 2024 Annual Meeting of Stockholders scheduled for May 3, 2024. The meeting will be held virtually, allowing stockholders to attend, vote, and submit questions online. The agenda includes the election of five directors to serve until the 2027 Annual Meeting, the ratification of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2024, advisory votes on executive compensation and the frequency of future stockholder advisory votes on executive compensation, and a management proposal to eliminate supermajority voting requirements. Additionally, three stockholder proposals will be considered if properly presented. The board recommends voting for the ratification of Ernst & Young LLP, for the approval of named executive officers' compensation, for annual advisory approvals of executive compensation, for the management proposal to eliminate supermajority voting, and against each of the stockholder proposals. The meeting will also address any other matters that may properly come before the meeting.
AbbVie Inc. (AbbVie) has announced the upcoming 2024 Annual Meeting of Stockholders scheduled for May 3, 2024. The meeting will be held virtually, allowing stockholders to attend, vote, and submit questions online. The agenda includes the election of five directors to serve until the 2027 Annual Meeting, the ratification of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2024, advisory votes on executive compensation and the frequency of future stockholder advisory votes on executive compensation, and a management proposal to eliminate supermajority voting requirements. Additionally, three stockholder proposals will be considered if properly presented. The board recommends voting for the ratification of Ernst & Young LLP, for the approval of named executive officers' compensation, for annual advisory approvals of executive compensation, for the management proposal to eliminate supermajority voting, and against each of the stockholder proposals. The meeting will also address any other matters that may properly come before the meeting.
艾伯维公司（AbbVie）宣布了即将于2024年5月3日举行的2024年年度股东大会。会议将以虚拟方式举行，允许股东在线出席、投票和提交问题。该议程包括选举五名董事，任期至2027年年会，批准安永会计师事务所为艾伯维2024年独立注册会计师事务所，关于高管薪酬的咨询投票和未来股东就高管薪酬进行咨询投票的频率，以及取消绝大多数投票要求的管理层提案。此外，如果提交得当，将考虑三份股东提案。董事会建议投票批准安永会计师事务所，批准指定执行官的薪酬，对高管薪酬的年度咨询批准，管理层取消绝大多数投票的提议，并反对每项股东提案。会议还将讨论可能在会议之前适当提出的任何其他事项。
艾伯维公司（AbbVie）宣布了即将于2024年5月3日举行的2024年年度股东大会。会议将以虚拟方式举行，允许股东在线出席、投票和提交问题。该议程包括选举五名董事，任期至2027年年会，批准安永会计师事务所为艾伯维2024年独立注册会计师事务所，关于高管薪酬的咨询投票和未来股东就高管薪酬进行咨询投票的频率，以及取消绝大多数投票要求的管理层提案。此外，如果提交得当，将考虑三份股东提案。董事会建议投票批准安永会计师事务所，批准指定执行官的薪酬，对高管薪酬的年度咨询批准，管理层取消绝大多数投票的提议，并反对每项股东提案。会议还将讨论可能在会议之前适当提出的任何其他事项。
有用
没用
